Chemo Group inaugurates mfg and R&D facilityIllustrative image – not actual.

Healthcare company Chemo Group has inaugurated its oral solids dosage manufacturing and R&D facility in Hyderabad, Telangana.

An initial investment of Rs 100 crore has been made in the new manufacturing and R&D facility.

The Indian arm of the group, Chemo India Formulation will make an investment of Rs 400-500 crore in the next four to five years. This is Phase-I; and in Phase-II, the unit will be expanded with an additional investment of Rs 75 crore to Rs 100 crore.

The company obtained five acre of land for the facility in 2015. Construction work began in July 2016 and was completed in July 2017.

The company will seek clearance from the Telangana Drug Regulator before seeking an audit from global regulators, like US Food and Drug Administration.

The facility is a 100 percent export-oriented unit and products manufactured in the unit will cater to global markets.

The company now has 15 plants around the world, employing 6,000 people.

 

← All latest storiesBack to top →